Timing of cyclosporin-A therapy for abrogation of HVG and GVH responses in rats
- PMID: 91782
- DOI: 10.1016/s0140-6736(79)92441-3
Timing of cyclosporin-A therapy for abrogation of HVG and GVH responses in rats
Abstract
Treatment with cyclosporin A was most effective in abrogating popliteal-lymph-node enlargement induced by host-versus-graft and graft-versus-host reactivity in rats when started before injection of donor-strain lymphocytes. Popliteal lymph-node enlargement was never completely abolished, and splenic lymphocytes from recipients treated with cyclosporin A showed no significant reduction in their response to donor-strain lymphocytes in mixed lymphocyte cultures, suggesting that clonal deletion had not taken place. Mixed lymphocyte cultures also indicated that cyclosporin treatment had not reduced the antigenicity of recipient lymphocytes towards donor strain.
Similar articles
-
Inhibition of alloreactivity in the popliteal lymph node assay by malononitrilamides.Transplant Proc. 1998 Jun;30(4):968-70. doi: 10.1016/s0041-1345(98)00113-4. Transplant Proc. 1998. PMID: 9636391 No abstract available.
-
Reactivation of allergic encephalomyelitis by means of allogeneic confrontation.Cell Immunol. 1985 Feb;90(2):614-9. doi: 10.1016/0008-8749(85)90226-6. Cell Immunol. 1985. PMID: 3967305
-
Early cellular events in a systemic graft-vs.-host reaction. I. The migration of responding and nonresponding donor lymphocytes.J Exp Med. 1975 Mar 1;141(3):664-80. doi: 10.1084/jem.141.3.664. J Exp Med. 1975. PMID: 235003 Free PMC article.
-
The popliteal lymph node graft-versus-host (GvH) reaction in the rat: a useful model for studying cell interactions in the immune response?Immunol Rev. 1985 Dec;88:153-68. doi: 10.1111/j.1600-065x.1985.tb01157.x. Immunol Rev. 1985. PMID: 3910555 Review.
-
Cyclosporin A.Transplantation. 1981 Nov;32(5):349-54. Transplantation. 1981. PMID: 6460358 Review. No abstract available.
Cited by
-
Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980.Blut. 1980 Sep;41(3):151-245. doi: 10.1007/BF02464145. Blut. 1980. PMID: 7000209 No abstract available.
-
Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection.Clin Exp Immunol. 1981 Jul;45(1):173-7. Clin Exp Immunol. 1981. PMID: 7030537 Free PMC article.
-
Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse.Clin Exp Immunol. 1983 Jun;52(3):599-606. Clin Exp Immunol. 1983. PMID: 6872317 Free PMC article.
-
Hepatic and renal function in rats receiving immunotherapeutic doses of cyclosporin A.Br J Exp Pathol. 1980 Dec;61(6):631-4. Br J Exp Pathol. 1980. PMID: 7459257 Free PMC article.
-
Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs.Immunology. 1983 Feb;48(2):301-8. Immunology. 1983. PMID: 6822404 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources